how many americans are on semaglutide Ozempic popularity among privately insured may worsen disparities Older Americans Quit Weight Loss

What if your medication pen malfunctions mid-trip

Eli Lilly's TRIUMPH Phase 3 program includes multiple trials across different populations: TRIUMPH-1: Obesity without type 2 diabetes (NCT05929066) TRIUMPH-4: Obesity with type 2 diabetes Additional trials: MASLD/NASH, cardiovascular outcomes, kidney outcomes What Trial Enrollment Includes Free study medication (retatrutide or placebo

most patients tolerate semaglutide well, especially when starting at the low 0.25 mg dose

JAMA 290:486494 Jil M, Rajnikant M, Richard D, Iskandar I (2017) The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: a retrospective cohort study